ASCO 2023 | Remaining unmet needs in pediatric Wilms’ tumor

Amy Armstrong, MD, Washington University School of Medicine, St. Louis, MO, comments on unanswered questions regarding the management of Wilms’ tumor in pediatric patients. Due to the very small number of cases, sufficient recruitment of patients for clinical trials are a challenge. Dr Armstrong additionally highlights several studies, including one assessing the molecular characterization of favorable Wilms’ tumor, and another investigating the efficacy of vincristine and irinotecan in anaplastic Wilms’ tumor. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.